falsefalse
Advertisement

Breakthroughs in Advanced Therapies for Treatment Resistant Depression - Episode 3

Esketamine for TRD: MOA, Application, and Adverse Events

Published on: 
, , ,

Robert Zalewski-Zaragoza, MD expands on the option of esketamine for treatment resistant depression, highlighting the unique mechanism of action and application.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      EP. 1: Impact and Costs of Treatment Resistant Depression
      EP. 2: Treatment Options for TRD
      Now Viewing
      EP. 3: Esketamine for TRD: MOA, Application, and Adverse Events
      EP. 4: Esketamine Safety Mechanisms and Bioavailability
      Advertisement
      Advertisement
      Advertisement
      x